Citigroup has published a research report on Humana Inc. HUM after the company reported a "messy" 4Q.
In the report, Citigroup writes "Earnings in the fourth quarter were $0.63 per share, $0.18 below consensus, mainly because of a $139 million ($0.51 per share) reserve charge related to a long-term care product Humana no longer sells. In addition, Humana made $35 million in charitable contributions ($0.13 per share), incurred $37 million ($0.13 per share) in costs associated with the launch of the Wal-Mart PDP, $40 million incremental costs associated with Medicare open enrollment ($0.15 per share), and $15 million ($0.05 per share) in Concentra transaction costs. In total, the one-time items amounted to $1.02 for the quarter, although they were likely partially offset by some one-time positive development."
Citigroup maintains its Buy rating and $65 price target.
Humana closed Friday at $59.24.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in